Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Therapeutics × Other × Clear all

Phase

Phase NA 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 7 Other hematologic neoplasm 6 Gastrointestinal 6 Dermatologic 6 Lymphoid 5 Plasma cell 4 Head & Neck 4 CNS 4 Breast 4 Sarcoma 3 Myeloid 3 Gynecologic 3 Tumor-Agnostic 1 Other solid neoplasm 1 Other neoplasm 1 Other 1 Endocrine 1 Classical hematology 1

Conditions

Mucositis 1 Head and Neck Neoplasms 1

Interventions

Radiotherapy 5 Surveys and Questionnaires 4 Cisplatin 4 Radiation 3 Injections 3 angiotensin I (1-7) 2 alvimopan 2 Water 2 Vitamin D 2 Tirzepatide 2 RRx-001 2 Mouthwashes 2 Interleukin 1 Receptor Antagonist Protein 2 Drug Therapy 2 Dexmedetomidine 2 Dexamethasone 2 Calcium Dobesilate 2 Amifostine 2 tempol 1 peppermint oil 1 pegfilgrastim 1 naloxegol 1 methylnaltrexone 1 linaclotide 1 licogliflozin 1 kang-lai-te 1 isatuximab 1 indole-3-carbinol 1 hydrated silica gel-based toothpaste 1 fish oil triglycerides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04046250 2023-08-25

TK112690

Tosk, Inc.

Phase 2 Completed

22 enrolled 10 charts

Head & NeckOther

Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡